Replies to post #173492 on Cytodyn Inc (CYDY)

[daemon57]

The FDA wants clinical data that show primary endpoints met and CytoDyn leadership is showing the resilience to provide it in the USA and abroad. Investors like the “13-D group”, the Motley Fool, or STAT News that can't connect these obvious dots are likely looking back at all the setbacks instead of the finish line right in front of their face and no amount of vision correction can help them.

Can't put it any further succinct than than that.

GLTU/A.

[Learning53]

Misiu,

The Zero Hedge Article (Re: CytoDyn's Potential Valuation) was very

UPLIFTING!!

I agree with Monroe - should buy some more CYDY. The current trend of overwelming short sales should jack the price down a few more cents tomorrow - just hope I can break free a little later Friday to put in an order or two. This thing goes day-by-day. ...And CYDY could turn on a dime (or more likely a few pennies) at any single moment.

13d is just shrill noise in the background. Deafening, but it will turn out to be inconsequential. A lot of things going on and any ONE comes in and they're instantly yesterday's news.


Great Post!